Kazia Therapeutics Limited - American Depositary Shares (KZIA)

filings reported holding KZIA - Kazia Therapeutics Limited - American Depositary Shares as of Q2 2024.
Kazia Therapeutics Limited - American Depositary Shares (KZIA) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 392K shares of 7.74M outstanding shares and own 5.06% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (201K shares), BNP PARIBAS FINANCIAL MARKETS (63.6K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (41.5K shares), Virtu Financial LLC (39.3K shares), UBS Group AG (23.3K shares), RHUMBLINE ADVISERS (17.6K shares), CITADEL ADVISORS LLC (4.57K shares), WELLS FARGO & COMPANY/MN (500 shares), Allworth Financial LP (87 shares), and AdvisorNet Financial, Inc (5 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.